Literature DB >> 2887725

Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.

M H Munshi, D A Sack, K Haider, Z U Ahmed, M M Rahaman, M G Morshed.   

Abstract

In an epidemic of shigellosis in southern Bangladesh the causal organism, Shigella dysenteriae type 1, was resistant to nalidixic acid as well as to co-trimoxazole (trimethoprimsulphamethoxazole) and ampicillin. The genes coding for resistance to nalidixic acid, but not those coding for resistance to co-trimoxazole or ampicillin, are located on a conjugative 20 megadalton plasmid. This epidemic is of particular importance because of the resistance to nalidixic acid, an antibiotic to which shigellae are seldom resistant, and because plasmids were previously thought not to mediate resistance to nalidixic acid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887725     DOI: 10.1016/s0140-6736(87)90957-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

Review 1.  In vitro antibacterial activity and pharmacodynamics of new quinolones.

Authors:  A Dalhoff; F-J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-04-01       Impact factor: 3.267

Review 2.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

3.  Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India.

Authors:  Gururaja Perumal Pazhani; Bhaswati Sarkar; Thandavarayan Ramamurthy; S K Bhattacharya; Yoshifumi Takeda; S K Niyogi
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

4.  The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal.

Authors:  K A Talukder; B K Khajanchi; M A Islam; D K Dutta; Z Islam; S I Khan; G B Nair; D A Sack
Journal:  Epidemiol Infect       Date:  2006-05-10       Impact factor: 2.451

Review 5.  Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A N Wadworth; K L Goa
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 6.  Plasmid-mediated 4-quinolone resistance: a real or apparent absence?

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 7.  Plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Jacob Strahilevitz; David C Hooper
Journal:  Microbiol Spectr       Date:  2014-10

8.  Plasmid analysis of Shigella dysenteriae type 1 isolates obtained from widely scattered geographical locations.

Authors:  K Haider; B A Kay; K A Talukder; M I Huq
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

Review 9.  Quinolones in urology.

Authors:  K T Nielsen; P O Madsen
Journal:  Urol Res       Date:  1989

Review 10.  Maintaining fluoroquinolone class efficacy: review of influencing factors.

Authors:  W Michael Scheld
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.